Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

HER2-positive Breast Cancer 1

Interventions

Exercise 126 Surveys and Questionnaires 59 Standard of Care 59 Early Intervention, Educational 55 Methods 54 Educational Status 53 Magnetic Resonance Spectroscopy 50 Acupuncture Therapy 48 Blood Specimen Collection 46 Radiotherapy 39 Mammography 39 Control Groups 35 Counseling 32 Therapeutics 30 Practice Guidelines as Topic 30 Cyclophosphamide 29 Biopsy 28 Sentinel Lymph Node Biopsy 27 Psychiatric Rehabilitation 27 Neoadjuvant Therapy 24 Yoga 23 Mastectomy, Segmental 23 Resistance Training 22 Interviews as Topic 21 Surgical Procedures, Operative 19 Palliative Care 19 High-Energy Shock Waves 19 Trastuzumab 18 Doxorubicin 18 Cognitive Behavioral Therapy 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Isovaleryl-CoA Dehydrogenase × Breast × Clear all

NCT07281001 2025-12-15

Traderrus

Blokhin's Russian Cancer Research Center

Phase NA Recruiting

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡